To investigate the impact of exogenous CXCL14 on the chemoresistance of bladder cancer, we collected and cultured patient-derived organoids (PDOs) from a bladder cancer patient who underwent radical cystectomy without prior therapy to assess the clinical relevance of our findings. Here, CXCL14 is linked to urinary bladder cancer.